Traditional Chinese medicine composition for preventing prostatic hyperplasia

Abstract

The invention relates to the technical field of traditional Chinese medicine and aims at providing a traditional Chinese medicine composition for preventing prostatic hyperplasia based on the prostatic hyperplasia knowing mechanism of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from, by weight, 10-20 parts of white atractylodes rhizomes, 8-12 parts of peach kernels, 5-15 parts of epimedium herb and 8-12 parts of prepared rehmannia roots. The traditional Chinese medicine composition is taken twice every day, and 10 days serve as a course of treatment. The traditional Chinese medicine composition is good in treating effect and free of toxic and side effect, the raw materials are easy to obtain, and the statistics of hundreds of patients with prostatic hyperplasia and taking the composition shows that the effective rate is up to 94%.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for preventing prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia: Prostatic hyperplasia is one of the common diseases of middle-aged and elderly men. With the aging of the global population, the incidence of benign prostatic hyperplasia increases with age, but there may not be clinical symptoms when there are hyperplasia lesions. The incidence rate in urban areas is higher than that in rural areas, and racial differences also affect the degree of hyperplasia. There are many studies on the pathogenesis of benign prostatic hyperplasia, but the cause has not yet been clarified. It is known that benign prostatic hyperplasia must have two conditions: functioning testis and increasing age In recent years, it has also noticed the relationship between smoking, obesity and alcoholism, family history,...

AI Technical Summary

Problems solved by technology

The incidence rate in urban areas is higher than that in rural areas, and racial differences also affect the degree of hyperplasia. There are many studies on the pathogenesis of benign prostatic hyperplasia, but the cause has not yet been clarified. It is known that benign prostatic hyperplasia must have two conditions: functioning testis and increasing age In recent years, it has also been noticed that smoking, obesity and alcoholism, family history, race and geographical environment are related to the occurrence of benign prostatic hyperplasia.

[0003] At present, most patients will take western medicine for treatment, but western medicine may cause liver and kidney function damage and other adverse reactions